
Kenvue, Inc. (KVUE), which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually high volume today.
KVUE is at $21.59 today, well off its highs after releasing disappointing Q1 sales results on May 8. That probably led to the CEO's ouster yesterday. But it could be a value investor's signal to consider buying into KVUE stock.